Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| COMMUNITY HEALTH SYSTEMS INCCYH · Entity 5628 | Pres,Chief Legal&Admin Officer | March 01, 2026 | March 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
COMMUNITY HEALTH SYSTEMS INC
Report date March 01, 2026 · Filed March 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 287,750 |
Ending reported balance
After 2026-03-01 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2026-03-01 · Exercise / conversion · Acquired 30,000 · Balance 272,672 F1: The vesting of these performance-based restricted shares was based on the Issuer's attainment of certain performance objectives between 1/1/2023 and 12/31/2025 (the "2023-2025 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2023-2025 Performance Period, the award vested on 3/1/2026 at 100% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2023. Row 2 · 2026-03-01 · Grant · Acquired 40,000 · Balance 312,672 F2: The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant. Row 3 · 2026-03-01 · Tax withholding · Disposed 24,922 · Balance 287,750 |
| Performance Based RestrictedSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2026-03-01 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-03-01 · Exercise / conversion · Disposed 30,000 · Balance 0 F1: The vesting of these performance-based restricted shares was based on the Issuer's attainment of certain performance objectives between 1/1/2023 and 12/31/2025 (the "2023-2025 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2023-2025 Performance Period, the award vested on 3/1/2026 at 100% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2023. |
| Performance Based RestrictedSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 80,000 |
Reported balance
After 2026-03-01 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-03-01 · Grant · Acquired 80,000 · Balance 80,000 F3: The vesting of these performance-based restricted shares is allocated to the Issuer's attainment of the following predetermined performance objectives between 1/1/2026 and 12/31/2028 (the "2026-2028 Performance Period"), as follows: 50% to a Cumulative Same-Store Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2026-2028 Performance Period. |
| Performance Based RestrictedSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 30,000 |
Reported balance
Holding disclosure · report date 2026-03-01 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 30,000 F5: The vesting of these performance-based restricted shares is subject to the Issuer's attainment of certain performance objectives between 1/1/2024 and 12/31/2026 (the "2024-2026 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2024-2026 Performance Period. |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.46 · Expires 2036-02-29 | Direct | 40,000 |
Reported balance
After 2026-03-01 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-03-01 · Grant · Acquired 40,000 · Balance 40,000 F4: Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant. |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.99 · Expires 2029-02-28 | Direct | 5,000 |
Reported balance
Holding disclosure · report date 2026-03-01 · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · Balance 5,000 |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.93 · Expires 2030-02-28 | Direct | 20,000 |
Reported balance
Holding disclosure · report date 2026-03-01 · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · Balance 20,000 |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.81 · Expires 2031-02-28 | Direct | 20,000 |
Reported balance
Holding disclosure · report date 2026-03-01 · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · Balance 20,000 |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $10.18 · Expires 2032-02-29 | Direct | 30,000 |
Reported balance
Holding disclosure · report date 2026-03-01 · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · Balance 30,000 |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.15 · Expires 2033-02-28 | Direct | 30,000 |
Reported balance
Holding disclosure · report date 2026-03-01 · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · Balance 30,000 |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.87 · Expires 2034-02-28 | Direct | 30,000 |
Reported balance
Holding disclosure · report date 2026-03-01 · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · Balance 30,000 F4: Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant. |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.01 · Expires 2035-02-28 | Direct | 40,000 |
Reported balance
Holding disclosure · report date 2026-03-01 · row 15
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 15 · Balance 40,000 F4: Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant. |
| Performanced Based RestrictedSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 80,000 |
Reported balance
Holding disclosure · report date 2026-03-01 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 80,000 F6: The vesting of these performance-based restricted shares is subject to the Issuer's attainment of certain performance objectives between 1/1/2025 and 12/31/2027 (the "2025-2027 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2025-2027 Performance Period. |
Filing footnotes · ownership attribution and instrument terms
F1: The vesting of these performance-based restricted shares was based on the Issuer's attainment of certain performance objectives between 1/1/2023 and 12/31/2025 (the "2023-2025 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2023-2025 Performance Period, the award vested on 3/1/2026 at 100% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2023.
F2: The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant.
F3: The vesting of these performance-based restricted shares is allocated to the Issuer's attainment of the following predetermined performance objectives between 1/1/2026 and 12/31/2028 (the "2026-2028 Performance Period"), as follows: 50% to a Cumulative Same-Store Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2026-2028 Performance Period.
F4: Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant.
F5: The vesting of these performance-based restricted shares is subject to the Issuer's attainment of certain performance objectives between 1/1/2024 and 12/31/2026 (the "2024-2026 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2024-2026 Performance Period.
F6: The vesting of these performance-based restricted shares is subject to the Issuer's attainment of certain performance objectives between 1/1/2025 and 12/31/2027 (the "2025-2027 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2025-2027 Performance Period.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 01, 2026 Filed Mar 3, 2026 21:46 UTC | COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 | GrantStock Options (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $3.46 | $0.00 |
DisclosureSEC source: 0001193125-26-088507 · ownership.xml · derivative · entry 6 Pitt Justin D · CIK 0001900988 · Pres,Chief Legal&Admin Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2036-02-29 F4 · derivative.exercise_date: Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 21:46 UTC | COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 | GrantPerformance Based Restricted · Derivative | 80,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-088507 · ownership.xml · derivative · entry 5 Pitt Justin D · CIK 0001900988 · Pres,Chief Legal&Admin Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires not disclosed F3 · derivative.exercise_date: The vesting of these performance-based restricted shares is allocated to the Issuer's attainment of the following predetermined performance objectives between 1/1/2026 and 12/31/2028 (the "2026-2028 Performance Period"), as follows: 50% to a Cumulative Same-Store Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2026-2028 Performance Period. F3 · derivative.expiration_date: The vesting of these performance-based restricted shares is allocated to the Issuer's attainment of the following predetermined performance objectives between 1/1/2026 and 12/31/2028 (the "2026-2028 Performance Period"), as follows: 50% to a Cumulative Same-Store Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2026-2028 Performance Period. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 21:46 UTC | COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 | Exercise / conversionPerformance Based Restricted · Derivative | 30,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-088507 · ownership.xml · derivative · entry 4 Pitt Justin D · CIK 0001900988 · Pres,Chief Legal&Admin Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The vesting of these performance-based restricted shares was based on the Issuer's attainment of certain performance objectives between 1/1/2023 and 12/31/2025 (the "2023-2025 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2023-2025 Performance Period, the award vested on 3/1/2026 at 100% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2023. F1 · derivative.expiration_date: The vesting of these performance-based restricted shares was based on the Issuer's attainment of certain performance objectives between 1/1/2023 and 12/31/2025 (the "2023-2025 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2023-2025 Performance Period, the award vested on 3/1/2026 at 100% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2023. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 21:46 UTC | COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 | Tax withholdingCommon Stock | 24,922 | $3.46 | $86,230.12 |
DisclosureSEC source: 0001193125-26-088507 · ownership.xml · nonDerivative · entry 3 Pitt Justin D · CIK 0001900988 · Pres,Chief Legal&Admin Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 287,750 Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 21:46 UTC | COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 | GrantCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-088507 · ownership.xml · nonDerivative · entry 2 Pitt Justin D · CIK 0001900988 · Pres,Chief Legal&Admin Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 312,672 F2 · shares: The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 21:46 UTC | COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 | Exercise / conversionCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-088507 · ownership.xml · nonDerivative · entry 1 Pitt Justin D · CIK 0001900988 · Pres,Chief Legal&Admin Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 272,672 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The vesting of these performance-based restricted shares was based on the Issuer's attainment of certain performance objectives between 1/1/2023 and 12/31/2025 (the "2023-2025 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2023-2025 Performance Period, the award vested on 3/1/2026 at 100% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2023. Read SEC document |
| March 01, 2025 Filed Mar 3, 2025 23:04 UTC | COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 | GrantStock Options (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $3.01 | $0.00 |
DisclosureSEC source: 0000950170-25-031113 · ownership.xml · derivative · entry 7 Pitt Justin D · CIK 0001900988 · Pres,Chief Legal&Admin Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2035-02-28 F4 · derivative.exercise_date: Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant. Read SEC document |
| March 01, 2025 Filed Mar 3, 2025 23:04 UTC | COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 | GrantPerformanced Based Restricted · Derivative | 80,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-031113 · ownership.xml · derivative · entry 6 Pitt Justin D · CIK 0001900988 · Pres,Chief Legal&Admin Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires not disclosed F3 · derivative.exercise_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2025 and 12/31/2027 (the "2025-2027 Performance Period"), as follows: 50% to a Cumulative Same-Store Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2025-2027 Performance Period. F3 · derivative.expiration_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2025 and 12/31/2027 (the "2025-2027 Performance Period"), as follows: 50% to a Cumulative Same-Store Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2025-2027 Performance Period. Read SEC document |
| March 01, 2025 Filed Mar 3, 2025 23:04 UTC | COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 | Disposition to issuerPerformance Based Restricted · Derivative | 23,700 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-031113 · ownership.xml · derivative · entry 5 Pitt Justin D · CIK 0001900988 · Pres,Chief Legal&Admin Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 23,700 shares Expires not disclosed F1 · derivative.exercise_date: The vesting of these 30,000 performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2022 and 12/31/2024 (the "2022-2024 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2022-2024 Performance Period, the award vested on March 1, 2025 at 21% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2022 (6,300), and the remaining 79% of the target number has been forfeited (23,700). F1 · derivative.expiration_date: The vesting of these 30,000 performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2022 and 12/31/2024 (the "2022-2024 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2022-2024 Performance Period, the award vested on March 1, 2025 at 21% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2022 (6,300), and the remaining 79% of the target number has been forfeited (23,700). Read SEC document |
| March 01, 2025 Filed Mar 3, 2025 23:04 UTC | COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 | Tax withholdingCommon Stock | 11,744 | $3.01 | $35,349.44 |
DisclosureSEC source: 0000950170-25-031113 · ownership.xml · nonDerivative · entry 3 Pitt Justin D · CIK 0001900988 · Pres,Chief Legal&Admin Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 242,672 Read SEC document |
| March 01, 2025 Filed Mar 3, 2025 23:04 UTC | COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 | GrantCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-031113 · ownership.xml · nonDerivative · entry 2 Pitt Justin D · CIK 0001900988 · Pres,Chief Legal&Admin Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 254,416 F2 · shares: The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant. Read SEC document |
| March 01, 2025 Filed Mar 3, 2025 23:04 UTC | COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 | Exercise / conversionCommon Stock | 6,300 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-031113 · ownership.xml · nonDerivative · entry 1 Pitt Justin D · CIK 0001900988 · Pres,Chief Legal&Admin Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 214,416 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The vesting of these 30,000 performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2022 and 12/31/2024 (the "2022-2024 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2022-2024 Performance Period, the award vested on March 1, 2025 at 21% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2022 (6,300), and the remaining 79% of the target number has been forfeited (23,700). Read SEC document |
| March 15, 2024 Filed Mar 15, 2024 20:31 UTC | COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 | Disposition to issuerCommon Stock | 5,001 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-032237 · ownership.xml · nonDerivative · entry 1 Pitt Justin D · CIK 0001900988 · EVP and General Counsel 10b5-1 filing: No plan indicated Ownership: Indirect · By spouse Disclosed balance after: 12,584 F1 · ownership.nature: The Reporting Person's spouse is no longer employed by an affiliate of the Issuer. The remaining unvested portion of her prior awards of restricted stock was forfeited in conjunction with her ceasing to be employed by an affiate of the Issuer. The Reporting Person disclaims beneficial ownership of the securities of the Issuer owned by his spouse, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Read SEC document |
| March 01, 2024 Filed Mar 2, 2024 00:57 UTC | COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 | GrantStock Options (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $2.87 | $0.00 |
DisclosureSEC source: 0000950170-24-024236 · ownership.xml · derivative · entry 7 Pitt Justin D · CIK 0001900988 · EVP and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2034-02-28 F5 · derivative.exercise_date: Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant. Read SEC document |
| March 01, 2024 Filed Mar 2, 2024 00:57 UTC | COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 | GrantPerformance Based Restricted · Derivative | 30,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-024236 · ownership.xml · derivative · entry 6 Pitt Justin D · CIK 0001900988 · EVP and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires not disclosed F4 · derivative.exercise_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2024 and 12/31/2026 (the "2024-2026 Performance Period"), as follows: 50% to a Cumulative Consolidated Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2024-2026 Performance Period. F4 · derivative.expiration_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2024 and 12/31/2026 (the "2024-2026 Performance Period"), as follows: 50% to a Cumulative Consolidated Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2024-2026 Performance Period. Read SEC document |
| March 01, 2024 Filed Mar 2, 2024 00:57 UTC | COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 | Exercise / conversionPerformance Based Restricted · Derivative | 20,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-024236 · ownership.xml · derivative · entry 5 Pitt Justin D · CIK 0001900988 · EVP and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2021 and 12/31/2023 (the "2021-2023 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2021-2023 Performance Period, the award vested on March 1, 2024 at 100% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2021. F1 · derivative.expiration_date: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2021 and 12/31/2023 (the "2021-2023 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2021-2023 Performance Period, the award vested on March 1, 2024 at 100% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2021. Read SEC document |
| March 01, 2024 Filed Mar 2, 2024 00:57 UTC | COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 | Tax withholdingCommon Stock | 1,484 | $2.87 | $4,259.08 |
DisclosureSEC source: 0000950170-24-024236 · ownership.xml · nonDerivative · entry 4 Pitt Justin D · CIK 0001900988 · EVP and General Counsel 10b5-1 filing: No plan indicated Ownership: Indirect · By spouse Disclosed balance after: 17,585 F3 · ownership.nature: The Reporting Person's spouse is employed by an affiliate of the Issuer. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purposes. Read SEC document |
| March 01, 2024 Filed Mar 2, 2024 00:57 UTC | COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 | Tax withholdingCommon Stock | 16,497 | $2.87 | $47,346.39 |
DisclosureSEC source: 0000950170-24-024236 · ownership.xml · nonDerivative · entry 3 Pitt Justin D · CIK 0001900988 · EVP and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 208,116 Read SEC document |
| March 01, 2024 Filed Mar 2, 2024 00:57 UTC | COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 | GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-024236 · ownership.xml · nonDerivative · entry 2 Pitt Justin D · CIK 0001900988 · EVP and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 224,613 F2 · shares: The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant. Read SEC document |
| March 01, 2024 Filed Mar 2, 2024 00:57 UTC | COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 | Exercise / conversionCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-024236 · ownership.xml · nonDerivative · entry 1 Pitt Justin D · CIK 0001900988 · EVP and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 194,613 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2021 and 12/31/2023 (the "2021-2023 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2021-2023 Performance Period, the award vested on March 1, 2024 at 100% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2021. Read SEC document |
| March 01, 2023 Filed Mar 2, 2023 21:32 UTC | COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 | GrantStock Options (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $6.15 | $0.00 |
DisclosureSEC source: 0001209191-23-014698 · doc4.xml · derivative · entry 8 Pitt Justin D · CIK 0001900988 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2033-02-28 F5 · derivative.exercise_date: Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant. Read SEC document |
| March 01, 2023 Filed Mar 2, 2023 21:32 UTC | COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 | GrantPerformance Based Restricted · Derivative | 30,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-014698 · doc4.xml · derivative · entry 7 Pitt Justin D · CIK 0001900988 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires not disclosed F4 · derivative.exercise_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2023 and 12/31/2025 (the "2023-2025 Performance Period"), as follows: 50% to a Cumulative Consolidated Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2023-2025 Performance Period. F4 · derivative.expiration_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2023 and 12/31/2025 (the "2023-2025 Performance Period"), as follows: 50% to a Cumulative Consolidated Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2023-2025 Performance Period. Read SEC document |
| March 01, 2023 Filed Mar 2, 2023 21:32 UTC | COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 | Exercise / conversionPerformance Based Restricted · Derivative | 20,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-014698 · doc4.xml · derivative · entry 6 Pitt Justin D · CIK 0001900988 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2020 and 12/31/2022 (the "2020-2022 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2020-2022 Performance Period, the award vested on March 1, 2023 at 100% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2020. F1 · derivative.expiration_date: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2020 and 12/31/2022 (the "2020-2022 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2020-2022 Performance Period, the award vested on March 1, 2023 at 100% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2020. Read SEC document |
| March 01, 2023 Filed Mar 2, 2023 21:32 UTC | COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 | Tax withholdingCommon Stock | 1,484 | $6.15 | $9,126.60 |
DisclosureSEC source: 0001209191-23-014698 · doc4.xml · nonDerivative · entry 5 Pitt Justin D · CIK 0001900988 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 19,069 F3 · ownership.nature: The Reporting Person's spouse is employed by an affiliate of the Issuer. Read SEC document |
| March 01, 2023 Filed Mar 2, 2023 21:32 UTC | COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 | GrantCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-014698 · doc4.xml · nonDerivative · entry 4 Pitt Justin D · CIK 0001900988 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 20,553 F2 · shares: The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant. F3 · ownership.nature: The Reporting Person's spouse is employed by an affiliate of the Issuer. Read SEC document |
| March 01, 2023 Filed Mar 2, 2023 21:32 UTC | COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 | Tax withholdingCommon Stock | 15,319 | $6.15 | $94,211.85 |
DisclosureSEC source: 0001209191-23-014698 · doc4.xml · nonDerivative · entry 3 Pitt Justin D · CIK 0001900988 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,613 Read SEC document |
| March 01, 2023 Filed Mar 2, 2023 21:32 UTC | COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 | GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-014698 · doc4.xml · nonDerivative · entry 2 Pitt Justin D · CIK 0001900988 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 189,932 F2 · shares: The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant. Read SEC document |
| March 01, 2023 Filed Mar 2, 2023 21:32 UTC | COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 | Exercise / conversionCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-014698 · doc4.xml · nonDerivative · entry 1 Pitt Justin D · CIK 0001900988 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,932 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2020 and 12/31/2022 (the "2020-2022 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2020-2022 Performance Period, the award vested on March 1, 2023 at 100% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2020. Read SEC document |
| March 01, 2023 Filed Mar 3, 2025 23:04 UTC | COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 | Exercise / conversionPerformance Based Restricted · Derivative | 6,300 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-031113 · ownership.xml · derivative · entry 4 Pitt Justin D · CIK 0001900988 · Pres,Chief Legal&Admin Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,700 Underlying: Common Stock · 6,300 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The vesting of these 30,000 performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2022 and 12/31/2024 (the "2022-2024 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2022-2024 Performance Period, the award vested on March 1, 2025 at 21% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2022 (6,300), and the remaining 79% of the target number has been forfeited (23,700). F1 · derivative.expiration_date: The vesting of these 30,000 performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2022 and 12/31/2024 (the "2022-2024 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2022-2024 Performance Period, the award vested on March 1, 2025 at 21% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2022 (6,300), and the remaining 79% of the target number has been forfeited (23,700). Read SEC document |
| March 02, 2022 Filed Mar 2, 2022 23:00 UTC | COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 | Tax withholdingCommon Stock | 17,087 | $10.18 | $173,945.66 |
DisclosureSEC source: 0001209191-22-015008 · doc4.xml · nonDerivative · entry 3 Pitt Justin D · CIK 0001900988 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,932 Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 23:00 UTC | COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 | GrantStock Options (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $10.18 | $0.00 |
DisclosureSEC source: 0001209191-22-015008 · doc4.xml · derivative · entry 8 Pitt Justin D · CIK 0001900988 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2032-02-29 F5 · derivative.exercise_date: Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 23:00 UTC | COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 | GrantPerformance Based Restricted · Derivative | 30,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-015008 · doc4.xml · derivative · entry 7 Pitt Justin D · CIK 0001900988 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires not disclosed F4 · derivative.exercise_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2022 and 12/31/2024 (the "2022-2024 Performance Period"), as follows: 50% to a Cumulative Consolidated Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2022-2024 Performance Period. F4 · derivative.expiration_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2022 and 12/31/2024 (the "2022-2024 Performance Period"), as follows: 50% to a Cumulative Consolidated Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2022-2024 Performance Period. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 23:00 UTC | COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 | Exercise / conversionPerformance Based Restricted · Derivative | 15,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-015008 · doc4.xml · derivative · entry 6 Pitt Justin D · CIK 0001900988 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2019 and 12/31/2021 (the "2019-2021 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2019-2021 Performance Period, the award vested on March 1, 2022 at 200% of the target number of the performance-based restricted shares originally granted to the reporting person on 3/1/2019. F1 · derivative.expiration_date: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2019 and 12/31/2021 (the "2019-2021 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2019-2021 Performance Period, the award vested on March 1, 2022 at 200% of the target number of the performance-based restricted shares originally granted to the reporting person on 3/1/2019. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 23:00 UTC | COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 | Tax withholdingCommon Stock | 1,385 | $10.18 | $14,099.30 |
DisclosureSEC source: 0001209191-22-015008 · doc4.xml · nonDerivative · entry 5 Pitt Justin D · CIK 0001900988 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 15,553 F3 · ownership.nature: The Reporting Person's spouse is employed by an affiliate of the Issuer. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 23:00 UTC | COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 | GrantCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-015008 · doc4.xml · nonDerivative · entry 4 Pitt Justin D · CIK 0001900988 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 16,938 F2 · shares: The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant. F3 · ownership.nature: The Reporting Person's spouse is employed by an affiliate of the Issuer. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 23:00 UTC | COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 | GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-015008 · doc4.xml · nonDerivative · entry 2 Pitt Justin D · CIK 0001900988 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,019 F2 · shares: The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 23:00 UTC | COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 | Exercise / conversionCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-015008 · doc4.xml · nonDerivative · entry 1 Pitt Justin D · CIK 0001900988 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,019 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2019 and 12/31/2021 (the "2019-2021 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2019-2021 Performance Period, the award vested on March 1, 2022 at 200% of the target number of the performance-based restricted shares originally granted to the reporting person on 3/1/2019. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.